| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/18/2008 | WO2008110247A1 Method for identifying the agonistic activity of a target compound on a potassium channel |
| 09/18/2008 | WO2008110044A1 Immune chromatographic strip disc for multiple analysis and detecting method by using it |
| 09/18/2008 | WO2008110006A1 Biomarkers of prostate cancer and uses thereof |
| 09/18/2008 | WO2008109992A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 09/18/2008 | WO2008109968A2 Non destructive monitoring of polymer dynamics |
| 09/18/2008 | WO2008109903A1 Diagnosis of septic complications |
| 09/18/2008 | WO2008090177A3 Diagnosis of prostate cancer |
| 09/18/2008 | WO2008089487A3 Carboxyethylpyrrole compounds and methods of their production |
| 09/18/2008 | WO2008089135A3 Identification of biomarkers predictive of dasatinib effects in cancer cells |
| 09/18/2008 | WO2008089112A3 Uniformly sized liposomes |
| 09/18/2008 | WO2008088524A3 Thrombospondin-domain-deficient r-spondin 1 protein as gastrointestinal tract epithelial proliferation factor |
| 09/18/2008 | WO2008087419A3 Animal model for adhd |
| 09/18/2008 | WO2008086259A3 Method of analyzing sulfur content in fuels |
| 09/18/2008 | WO2008083972A3 Method for removing prion protein |
| 09/18/2008 | WO2008080113A3 Impedance spectroscopy (is) methods and systems for characterizing fuel |
| 09/18/2008 | WO2008074813A3 Optiogenin for the treatment of neural diseases |
| 09/18/2008 | WO2008070816A3 Staphylococcal two helix binding protein |
| 09/18/2008 | WO2008067666A8 Allosteric modulation of ship polypeptides and uses thereof |
| 09/18/2008 | WO2008065451A3 Compositions comprising macromolecular assemblies of lipid and surfactant |
| 09/18/2008 | WO2008061104A3 Methods and kits for detecting prostate cancer biomarkers |
| 09/18/2008 | WO2008058103A9 Assays useful in determining cd38 inhibition |
| 09/18/2008 | WO2008055671A3 Method for the purification of at least one target substance that is to be identified |
| 09/18/2008 | WO2008042286A3 Method and apparatus for controlling fcc hydrotreating by near-infrared spectroscopy |
| 09/18/2008 | WO2008032073A3 Novel nematode protein and its use in producing anthelminthic agents and vaccines |
| 09/18/2008 | WO2008011387B1 Preparation of a red blood cell component for a hematology control |
| 09/18/2008 | WO2008002462A3 Methods and devices for microfluidic point-of-care immunoassays |
| 09/18/2008 | WO2007149948A3 Compositions and methods for diagnosis and treatment of tumors |
| 09/18/2008 | WO2007120553A3 System and method for estimating filtrate contamination in formation fluid samples using refractive index |
| 09/18/2008 | WO2007118218A3 Detection of silica species in hot phosphoric acid |
| 09/18/2008 | WO2007103100A3 Integrated microfluidics for parallel screening of chemical reactions |
| 09/18/2008 | WO2007079284A3 Lung cancer diagnostic assay |
| 09/18/2008 | WO2007071257A8 Method for dissolution testing of pharmaceutical products |
| 09/18/2008 | US20080229436 Methods for identifying modulators of lifespan and resistance to oxidative stress |
| 09/18/2008 | US20080229435 Using mitogen activated kinase as tool in identifying modulators for treatment and prevention of cell proliferative disorders |
| 09/18/2008 | US20080228589 Methods For Placing, Accepting, And Filling Orders For Products and Services |
| 09/18/2008 | US20080228408 Method for Determining the State of an Ensemble of Cells and System for the Implementation of the Method |
| 09/18/2008 | US20080228406 System and method for fungal identification |
| 09/18/2008 | US20080228404 Systems and methods for high-speed image scanning |
| 09/18/2008 | US20080228339 Apparatus and Method for Determining Remaining Transmission Oil Life |
| 09/18/2008 | US20080228102 Alpha-numeric and color indica for container sections; creating a three-dimensional, computer-generated graphic from collected specimens; transperineal saturation biopsy of the prostate gland |
| 09/18/2008 | US20080227973 Use of Phthalocyanines as Marking Substances for Liquids |
| 09/18/2008 | US20080227959 Immunogenic compounds for producing antibodies to efavirenz; monoclonal antibodies; immunoassays for selectively determining efavirenz levels in plasma; treatment failure and central nervous system side effects due to low and high plasma levels, respectively |
| 09/18/2008 | US20080227956 Novel morphogenic protein compositions of matter |
| 09/18/2008 | US20080227848 Identifying agent which modulates 2-oxoglutarate dependent oxygenase; ankyrin substrate; hypoxia-inducible factor; thalassemia |
| 09/18/2008 | US20080227827 Compounds that abrogate dna damage induced cell cycle g2 checkpoint and/or augment anti-cancer activity of dna-damaging treatments |
| 09/18/2008 | US20080227793 2-(1-Imidazomethyl)- or 2-(1-imidazooxy)-substituted, e.g., 6-chloro-2-{[2-(2-fluorophenyl)-1H-imidazol-1-yl]methyl}-1-propyl1H-benzimidazole; GABA receptor signal transduction; anxiety, antidepressants, sleep disorders, schizophrenia, attention deficit-hyperactivity disorder, memory enhancement |
| 09/18/2008 | US20080227754 Phosphoramidate linkages; retroviral or hepadnaviral therapy; tissue targeted therapy; HIV/aquired immunodeficiency syndrome; antitumor agents; improved bioavailability |
| 09/18/2008 | US20080227750 Complex of glycan and galactin accumulated on cell surfaces; therapy, prevention of autoimmune diseases |
| 09/18/2008 | US20080227741 Zap-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (cll/sll) |
| 09/18/2008 | US20080227738 Compositions and methods for cell dedifferentiation and tissue regeneration |
| 09/18/2008 | US20080227734 Mutant Lrp5/6 Wnt-Signaling Receptors in Cancer Diagnosis, Prognosis, and Treatment |
| 09/18/2008 | US20080227719 administering to a patient an effective dosage of a polypeptide comprising an N-terminal segment of A beta , the segment beginning at residue 1-3 of A beta and ending at residues 7-11 of A beta to treat disease associated with amyloid deposit of A beta in the brain Alzheimer's disease, Down's syndrome |
| 09/18/2008 | US20080227718 administering to a patient an effective dosage of a polypeptide comprising an N-terminal segment of A beta , the segment beginning at residue 1-3 of A beta and ending at residues 7-11 of A beta to treat disease associated with amyloid deposit of A beta in the brain Alzheimer's disease, Down's syndrome |
| 09/18/2008 | US20080227713 amino acid sequence of Ser1-Pro2-Lys3-Met4-Val5-Gln6-Gly7-Ser8-Gly9-Cys10-Phe11-Gly12-Arg13-Lys14-Met15-Asp16-Arg17-Ile18-Ser19-Ser20-Ser21-Ser22-Gly23-Leu24-Gly25-Cys26-Lys27-Val28-Leu29-Arg30-Lys31-His32, either Met4, Met15, or both are oxidized; diagnosis heart failure |
| 09/18/2008 | US20080227709 Gene expression in peripheral blood mononuclear cells from children with diabetes |
| 09/18/2008 | US20080227706 Polypeptides and polynucleotides; genetic engineering; medical diagnosis; treatment of infection causes sepsis, meningitis, pneumonia, cellulitis, osteomyelitis, septic arthritis, endocarditis or epiglottis; bacterial protein antigen vaccine |
| 09/18/2008 | US20080227703 neublastin neurotrophic factor polypeptides for treating neuropathy |
| 09/18/2008 | US20080227700 contacting the protein with a polypeptide up to about 50 amino acids in length having molecular chaperone activity; protein conformation disease is Alexander's disease, Alzheimer's disease, Creutzfeld-Jakob disease, Parkinson's disease, Huntington's disease, cataract, retinitis pigmentosa, prion disease |
| 09/18/2008 | US20080227697 Bacterial protein phosphoinositide probes and effectors |
| 09/18/2008 | US20080227695 reduced expression and/or function of Dlg (discs large) is an important factor for tumor formation; measuring the expression and/or function of Dlg |
| 09/18/2008 | US20080227694 Protein composed of sequence number 1 or 2; proteasome and polyubiquitin chain inhibitors; interaction with ZNF216 and/or AWP1 |
| 09/18/2008 | US20080227654 Method for sequencing nucleic acid molecules |
| 09/18/2008 | US20080227652 Dna Array for Analyzing Dna Methylation, Method of Producing the Same and Method of Analyzing Dna Methylation |
| 09/18/2008 | US20080227222 Method for the detection of target molecules by fluorescence polarization using peptide mimics |
| 09/18/2008 | US20080227221 Fluorescence Polarization-Based Homogeneous Assay For Aflatoxins |
| 09/18/2008 | US20080227220 Lateral Flow Binding Assay |
| 09/18/2008 | US20080227219 Dry composition comprising labeled binding partner for use as an assay positive control/calibrator |
| 09/18/2008 | US20080227218 Using spectrum analysis to monitor antigen-antibody reaction |
| 09/18/2008 | US20080227213 Comprising polymer backbone and two or more pendant RNA binding ligands; myotonic dystrophy |
| 09/18/2008 | US20080227212 Process for identifying existence of single nucleotide polymorphism without dna sequencing |
| 09/18/2008 | US20080227210 Point of care apparatus for monitoring blood glucose concentration; diagnosing diabetes |
| 09/18/2008 | US20080227209 Methods, Kits And Devices For Analysis Of Lipoprotein(a) |
| 09/18/2008 | US20080227208 Using blood component specific immunoglobulin to detect hemoglobin, transferrin, hemoglobin-haptoglobin complex and/or albumin in feces; diagnosing colorectal cancer |
| 09/18/2008 | US20080227207 Improves the accuracy of determining saccharide concentration |
| 09/18/2008 | US20080227206 Method and system for determination of molecular interaction parameters |
| 09/18/2008 | US20080227194 Lipolytic enzyme specific antibody for use in diagnosis of pancreatitis |
| 09/18/2008 | US20080227193 Expression vector coding oxidoreductase for use in identifying modulators which prevent parasitic worm infection; nematocides; biological pest control |
| 09/18/2008 | US20080227187 Bioreactor comprising biosensor electrodes for use in monitoring cellular response in xenpous oocytes |
| 09/18/2008 | US20080227183 Apparatus for supporting diagnosis of cancer |
| 09/18/2008 | US20080227156 Nucleotide sequences coding myostatin epitopes for use in treatment and prevention of diabetic disorders; immunotherapy |
| 09/18/2008 | US20080227144 Tissue sample support and orientation device |
| 09/18/2008 | US20080227142 Invasive chemometry |
| 09/18/2008 | US20080227138 Identifying sclerostin antagonist via abilty to prevent apoptosis; treating osteoporosis |
| 09/18/2008 | US20080227135 Autoimmune Conditions and NADPH Oxidase Defects |
| 09/18/2008 | US20080227132 Hydrolase Enzymes and Their Use in Kinetic Resolution |
| 09/18/2008 | US20080227127 Human NK3-Related Prostate Specific Gene-1 |
| 09/18/2008 | US20080227126 Apparatus comprising water repellent resin film and immobilized antibodies for use in measuring antigen concentration; immunoassay |
| 09/18/2008 | US20080227125 Using cardiovascular disorder plasma polypeptides (CPPs) as evaluative tools in detection coronary artery disease |
| 09/18/2008 | US20080227124 Multilayer support of polylactone or polyamide and cationic polymer; bioassay; kits |
| 09/18/2008 | US20080227123 Methods for Specifically Selecting Antibody-Producing Cells |
| 09/18/2008 | US20080227122 P2y purinergic receptor expression for identifying preneoplastic and neoplastic states |
| 09/18/2008 | US20080227121 Using collagen XIII peptide as evaluative tool in identifying modulators monocyte efflux into interstitial space; treating chronic inflammatory disorders |
| 09/18/2008 | US20080227120 Using fluorescence resonance transfer imaging to identify modulators of membrane-bound receptor/ligand complexes associated with inhibiting intracellular release of low density lipoprotein-cholesterol (LDL-C) from LDL receptors (LDL-R) |
| 09/18/2008 | US20080227119 ELISA for VEGF |
| 09/18/2008 | US20080227118 Protein Immobilization Method and Quantification Method |
| 09/18/2008 | US20080227117 Antitrypsin peptide marker for use in diagnosis and treatment of chronic obstructive pulmonary disease |
| 09/18/2008 | US20080227116 Histaminase Determination |
| 09/18/2008 | US20080227115 Inhibition of cancer metastasis |
| 09/18/2008 | US20080227114 Compositions and methods for modulating c-rel-dependent cytokine production |
| 09/18/2008 | US20080227113 Lipocalin-type prostaglandin D2 synthase specific monoclonal antibody for use in diagnosis of nervous system trauma and dysfunction |